New Medicare Rules May Curb Use of Anemia Drugs for Dialysis

Monday, July 26, 2010 - 18:42 in Mathematics & Economics

Amgen's Epogen may be affected significantly through new rules issued by Medicare.

Read the whole article on NY Times Health

More from NY Times Health

Learn more about

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net